Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on: January 22,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on:January 22,2024

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi

Updated on: March 01,2024

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi

Updated on:March 01,2024

Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainVitamin D levels affect overall survival for melanoma (skin cancer) patients, a new study presented at the 31stEuropean

Updated on: January 30,2024

Vitamin D deficiency in melanoma patients associated with worse overall survival, new study finds

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainVitamin D levels affect overall survival for melanoma (skin cancer) patients, a new study presented at the 31stEuropean

Updated on:January 30,2024

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

by SingHealthCredit: Pixabay/CC0 Public DomainAn international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre

Updated on: March 06,2024

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

by SingHealthCredit: Pixabay/CC0 Public DomainAn international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre

Updated on:March 06,2024

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Updated on: April 22,2024

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Updated on:April 22,2024

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre

Updated on: May 13,2024

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre

Updated on:May 13,2024

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that

Updated on: May 21,2024

More aggressive treatment doesn't impact quality of life for metastatic colorectal cancer patients, says new study

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNewresearchin the October 2023 issue ofJournal of the National Comprehensive Cancer Networkfinds that

Updated on:May 21,2024

Predicting cancer versus autism risk in PTEN patients

by Cleveland ClinicIn a newly published study, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may p

Updated on: May 07,2024

Predicting cancer versus autism risk in PTEN patients

by Cleveland ClinicIn a newly published study, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may p

Updated on:May 07,2024

Researchers map intricacies of lung cancer in one of their own

by Krista Conger,Stanford University Medical CenterJames Spudich (left) made an unusual offer last fall to colleague Mark Krasnow: a sample of a lung tumor that was to be removed from Spudich th

Updated on: June 04,2024

Researchers map intricacies of lung cancer in one of their own

by Krista Conger,Stanford University Medical CenterJames Spudich (left) made an unusual offer last fall to colleague Mark Krasnow: a sample of a lung tumor that was to be removed from Spudich th

Updated on:June 04,2024

Researchers identify one driver of melanoma spread

by Amy Mone,Johns Hopkins UniversityCredit: AI-generated imageUsing a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in

Updated on: June 22,2024

Researchers identify one driver of melanoma spread

by Amy Mone,Johns Hopkins UniversityCredit: AI-generated imageUsing a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in

Updated on:June 22,2024

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on: February 23,2024

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on:February 23,2024

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on: April 14,2024

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on:April 14,2024